Literature DB >> 26197955

HypoxamiRs: regulators of cardiac hypoxia and energy metabolism.

Hamid El Azzouzi1, Stefanos Leptidis2, Pieter A Doevendans1, Leon J De Windt3.   

Abstract

Hypoxia and its intricate regulation are at the epicenter of cardiovascular research. Mediated by hypoxia-inducible factors as well as by several microRNAs, recently termed 'hypoxamiRs', hypoxia affects several cardiac pathophysiological processes. Hypoxia is the driving force behind the regulation of the characteristic metabolic switch from predominant fatty acid oxidation in the healthy heart to glucose utilization in the failing myocardium, but also instigates reactivation of the fetal gene program, induces the cardiac hypertrophy response, alters extracellular matrix composition, influences mitochondrial biogenesis, and impacts upon myocardial contractility. HypoxamiR regulation adds a new level of complexity to this multitude of hypoxia-mediated effects, rendering the understanding of the hypoxic response a fundamental piece in solving the cardiovascular disease puzzle.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cardiovascular disease; hypoxamiRs; hypoxia; microRNAs; therapeutics

Mesh:

Substances:

Year:  2015        PMID: 26197955     DOI: 10.1016/j.tem.2015.06.008

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  27 in total

1.  Steroid receptor coactivator-2 (SRC-2) coordinates cardiomyocyte paracrine signaling to promote pressure overload-induced angiogenesis.

Authors:  Ji Ho Suh; Li Lai; Deokhwa Nam; Jong Kim; Juyeon Jo; George E Taffet; Eunah Kim; Jason T Kaelber; Hyun-Kyoung Lee; Mark L Entman; John P Cooke; Erin L Reineke
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

2.  Spexin protects cardiomyocytes from hypoxia-induced metabolic and mitochondrial dysfunction.

Authors:  Yang Liu; Li Sun; Linqun Zheng; Mengqi Su; He Liu; Ying Wei; Dan Li; Yike Wang; Chenguang Dai; Yongtai Gong; Chenyang Zhao; Yue Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-08       Impact factor: 3.000

3.  Hypoxia drives cardiac miRNAs and inflammation in the right and left ventricle.

Authors:  Philippe Chouvarine; Ekaterina Legchenko; Jonas Geldner; Christian Riehle; Georg Hansmann
Journal:  J Mol Med (Berl)       Date:  2019-07-23       Impact factor: 4.599

Review 4.  MicroRNA therapeutic targets in neonatal hypoxic-ischemic brain injury: a narrative review.

Authors:  Eric S Peeples
Journal:  Pediatr Res       Date:  2022-07-19       Impact factor: 3.953

Review 5.  Hypoxia-Induced circRNAs in Human Diseases: From Mechanisms to Potential Applications.

Authors:  Qi Huang; Juan Yang; Robby Miguel Wen-Jing Goh; Mingliang You; Lingzhi Wang; Zhaowu Ma
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

Review 6.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 7.  Role of miRNAs in hypoxia-related disorders.

Authors:  A Gupta; R Sugadev; Y K Sharma; Y Yahmad; P Khurana
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

8.  Hyperoside protects cardiomyocytes against hypoxia‑induced injury via upregulation of microRNA‑138.

Authors:  Siyi He; Xiaoqiang Yin; Fan Wu; Shaojie Zeng; Feng Gao; Mei Xin; Jian Wang; Jie Chen; Le Zhang; Jinbao Zhang
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

Review 9.  Role of microRNA in metabolic shift during heart failure.

Authors:  Mark V Pinti; Quincy A Hathaway; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-14       Impact factor: 4.733

Review 10.  Sestrin2 in hypoxia and hypoxia-related diseases.

Authors:  Xiaojing Che; Jiagui Chai; Yan Fang; Xifeng Zhang; Anju Zu; Lin Li; Shibo Sun; Weimin Yang
Journal:  Redox Rep       Date:  2021-12       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.